Results 261 to 270 of about 310,082 (306)
Some of the next articles are maybe not open access.

G-CSF bei Radiochemotherapie

Strahlentherapie und Onkologie, 1997
Hintergrund G-CSF (granulocyte-colony-stimulating-factor) beschleunigt die Teilung, Reifung und Freisetzung von Vorlauferzellen der Granulozyten. Die Verkurzung von chemotherapieinduzierten Leukopenien durch G-CSF-Gabe ist in der Literatur hinreichend beschrieben, unter alleiniger fraktionierter Radiotherapie zeigt sich ein meist deutliches Ansteigen ...
M. Riepl, R. Fietkau, R. Sauer
openaire   +1 more source

[G-CSF treatment].

Nihon rinsho. Japanese journal of clinical medicine, 2016
In acute phase of ischemic stroke, as neuroprotective and neurogenerative role of granulocyte-colony stimulating factor(G-CSF), anti-apoptotic action, anti-inflammatory and anti-immune effect, and brain protective action against excitatory neurotoxicity have been reported.
Atsushi, Mizuma, Shunya, Takizawa
openaire   +1 more source

Ischemic cardiac complications following G‐CSF

Catheterization and Cardiovascular Interventions, 2010
AbstractGranulocyte‐colony stimulating factor (G‐CSF) is commonly used in bone marrow transplant donors to increase the number of circulating progenitor cells. G‐CSF has also been studied following myocardial infarction, but concern has been raised about the risks of G‐CSF administration in patients with coronary artery disease. We present two cases of
Peter M, Eckman   +3 more
openaire   +2 more sources

G-CSF for Extensive STEMI.

Circulation research, 2019
In the exploratory Phase II STEM-AMI (Stem Cells Mobilization in Acute Myocardial Infarction) trial, we reported that early administration of G-CSF (granulocyte colony-stimulating factor), in patients with anterior ST-segment-elevation myocardial infarction and left ventricular (LV) dysfunction after successful percutaneous coronary intervention, had ...
Achilli F.   +24 more
openaire   +2 more sources

G-CSF-Prophylaxe unverzichtbar

InFo Onkologie, 2017
Die dosisdichte Chemotherapie in der Adjuvanz ist bei Hochrisikopatientinnen mit fruhem Brustkrebs zur Prognoseverbesserung etabliert. Dabei kann auf die supportive Gabe eines G-CSF-Praparates nicht verzichtet werden, um die Behandlung sicher durchfuhren zu konnen.
openaire   +1 more source

G-CSF - an anti-inflammatory cytokine-

Shock, 1995
We have previously reported that in various macrophage populations prepared from G-CSF treated rats LPS-inducible TNF release was suppressed. In vitro, LPS induced liver cell death only when hepatocytes were cocultured with liver macrophages.
T. Hartung, H-D. Volk, A. Wendel
openaire   +1 more source

G-CSF-induced carotid inflammation

The Lancet Oncology, 2022
Harshabad, Singh   +2 more
openaire   +2 more sources

[G-CSF in oncology].

Bulletin du cancer, 2006
Neutropenia and its subsequent infectious complications represent the most common dose-limiting toxicity of cancer chemotherapy. Febrile neutropenia (FN) occurs with common chemotherapy regimens in 25 to 40 % of treatment-naive patients, and its severity depends on the dose intensity of the chemotherapy regimen, the patient's prior history and ...
Frédéric, Viret   +4 more
openaire   +1 more source

[G-CSF in radiochemotherapy].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1997
G-CSF enhances the division, maturation and release of granulocyte precursor cells. The shortening of chemotherapy-induced leukopenia via G-CSF is well documented in literature, with fractionated radiotherapy alone one finds a distinct increase of the granulocyte level.
M, Riepl, R, Fietkau, R, Sauer
openaire   +1 more source

Home - About - Disclaimer - Privacy